跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION
Approved
STANDARD
LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION
Bausch + Lomb Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 30, 2022
Approval ID
270e175dad500117
Company
Bausch + Lomb Ireland Limited
Type
Standard
Approval Details
Approval Id
270e175dad500117
Drug Cima Aemps Name
LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION
Register Number
88470
Holder Company Name
Bausch + Lomb Ireland Limited
Marketing Company Name
Bausch & Lomb S.A.
Holder Company Detail Path
/organization/bausch-lomb-ireland-limited
Authorization Date
2022-12-30
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
0,25 MG/ML
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Bausch + Lomb Ireland Limited
Company Detail Path
/organization/bausch-lomb-ireland-limited
Company Information
Pharmaceutical Company Name
BAUSCH + LOMB IRELAND LIMITED
Country Name
Ireland
City Name
waterford,country_ie
Address
BAUSCH + LOMB VISION CARE
Active Ingredients
BRIMONIDINA TARTRATO
0,25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 30, 2022
Approval ID
270e175dad500117
Type
Standard
Back to CIMA-AEMPS Approvals